Ironwood Investment Management LLC Red Hill Biopharma Ltd. Transaction History

Ironwood Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$2.31 - $5.85 $89,122 - $225,698	-38,581 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$6.98 - $11.29 $127,405 - $206,076	18,253 Added 89.79%	38,581 $282,000
Q4 2020 Feb 12, 2021	SELL	$7.81 - $10.39 $54,537 - $72,553	-6,983 Reduced 25.57%	20,328 $164,000
Q1 2020 May 14, 2020	BUY	$3.51 - $6.17 $32,165 - $56,541	9,164 Added 50.5%	27,311 $124,000
Q3 2019 Nov 13, 2019	BUY	$6.46 - $8.37 $117,229 - $151,890	18,147 New	18,147 $128,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Ironwood Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ironwood Investment Management LLC with notifications on news.